Paper39159503
Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages.
Lu J and 10 others. Phytomedicine, 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages. Papers, record 39159503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39159503
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycyrrhizic Acid | Major topic |
| Concanavalin A | Major topic |
| Macrophages | Major topic |
| Chemical and Drug Induced Liver Injury | Major topic |
| Animals | |
| Mice | |
| Hepatitis, Autoimmune | |
| Mice, Inbred C57BL | |
| Liver | |
| Cytokines | |
| Male | |
| Anti-Inflammatory Agents |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42965739 | Modulating the osteoimmune microenvironment: biomaterial strategies for bone regeneration and implant integration. | Hum Cell | 2026 | https://conductscience.org/library/papers/42965739 | PubMed |
| 42932011 | Integrated bulk and single-cell transcriptomics with virtual knockout analysis identifies FOS as an epithelial-associated candidate gene in chronic atrophic gastritis. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42932011 | PubMed |
| 42866300 | Glycyrrhizic acid attenuates sepsis-induced acute lung injury by regulating macrophage M2 polarization via PRKCD. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42866300 | PubMed |
| 42666651 | Spatial immune niche remodeling of the neutrophil-macrophage axis inchronic liver disease. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42666651 | PubMed |
| 42477763 | Adoptive transfer of VSIG4+ macrophages interrupts the CCL2-CCR2 inflammatory amplification loop to mitigate acetaminophen-induced acute liver injury in murine and human organoid models. | J Transl Med | 2026 | https://conductscience.org/library/papers/42477763 | PubMed |
| 42396443 | Revealing the pathogenesis of autoimmune hepatitis and research progress in drug discovery from hepatic immune cells and intercellular communication signaling mechanisms. | Front Immunol | 2026 | https://conductscience.org/library/papers/42396443 | PubMed |
| 42307888 | Therapeutic potential of glycyrrhizic acid in inflammation-related diseases: from HMGB1-oriented molecular insights to preclinical application. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/42307888 | PubMed |
| 42298622 | Dietary glycyrrhizic acid improves growth performance and modulates upper respiratory microbiota in weaned piglets. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/42298622 | PubMed |
| 42178778 | A multicentre randomized open-label phase 2 trial of dexamethasone plus glycyrrhizinate versus dexamethasone in newly diagnosed immune thrombocytopenia. | Br J Haematol | 2026 | https://conductscience.org/library/papers/42178778 | PubMed |
| 42147312 | Glycyrrhizin preparations in liver diseases: a narrative review of mechanisms and therapeutic potential. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42147312 | PubMed |
| 41307794 | Macrophage-derived exosomes in autoimmune diseases: mechanistic insights and therapeutic implications. | Immunol Res | 2025 | https://conductscience.org/library/papers/41307794 | PubMed |
| 41170366 | Development and preliminary mechanistic analysis of compound effervescent hepatoprotective granules. | Front Nutr | 2025 | https://conductscience.org/library/papers/41170366 | PubMed |
| 40696369 | Qu-zhuo-tong-bi decoction exerts gouty arthritis therapy by skewing macrophage polarization through butanoate metabolism. | Chin Med | 2025 | https://conductscience.org/library/papers/40696369 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39159503
GET https://conductscience.org/api/papers/v1/39159503/authors